This application will test the hypothesis that SP-A play a critical role in lung function during adenoviral mediated lung injury by modulated 1) host defense, 2) inflammatory responses, and 3) surfactant homeostasis, by interacting with surface receptors on respiratory epithelial cells and alveolar macrophages. We propose that SP-A serves complex regulatory roles in the lung, binding to cell surface receptors present on Type II cells and alveolar macrophages, influencing 1) binding, uptake and killing of microorganisms and 2) inflammatory responses of epithelial cells and alveolar macrophages to microorganisms. The application will utilize models in which the synthesis of SP-A is altered genetically, using SP-A/-, SP-A+/+ mice or by intratracheal instillation of purified mouse SP-A. SP-A will be replaced genetically, in distinct subsets of respiratory epithelial cells. SP-A deficient and replete mice will be exposed to adenovirus to determine the role of P-A in lung inflammation and function. The studies will discern the concentration dependent and region-specific role of SP-A in innate defense and in surfactant homeostasis in the lung. We will determine the molecular mechanisms controlling SP-A gene transcription in the normal lung and after adenoviral induced inflammation. The role of SP-A in the modulation of respiratory epithelial cells and alveolar macrophage responses to a pro- inflammatory stimulus induced by adenovirus will be assessed. We propose that SO-A interacts in complex ways with multiple receptors n target cells, including epithelial cells and alveolar macrophages. We will identify, clone and assess binding specificity of the SP-A/Clq receptor/binding protein that is proposed to mediate, at least in part, SPA-function. These studies will help clarify the role of SP-A in innate defense of the lung and provide the basis for future therapies to maintain endogenous or supply exogenous SP-A to prevent morbidity or bacterial infection.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
1P01HL061646-01A1
Application #
6191714
Study Section
Project Start
1999-08-10
Project End
2000-06-30
Budget Start
Budget End
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Whitsett, Jeffrey A; Weaver, Timothy E (2015) Alveolar development and disease. Am J Respir Cell Mol Biol 53:1-7
Conkright, Juliana J; Apsley, Karen S; Martin, Emily P et al. (2010) Nedd4-2-mediated ubiquitination facilitates processing of surfactant protein-C. Am J Respir Cell Mol Biol 42:181-9
Xu, Yan; Zhang, Minlu; Wang, Yanhua et al. (2010) A systems approach to mapping transcriptional networks controlling surfactant homeostasis. BMC Genomics 11:451
Suzuki, Takuji; Sakagami, Takuro; Young, Lisa R et al. (2010) Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy. Am J Respir Crit Care Med 182:1292-304
Hardie, William D; Hagood, James S; Dave, Vrushank et al. (2010) Signaling pathways in the epithelial origins of pulmonary fibrosis. Cell Cycle 9:2769-76
Whitsett, Jeffrey A; Wert, Susan E; Weaver, Timothy E (2010) Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease. Annu Rev Med 61:105-19
Kramer, Elizabeth L; Mushaben, Elizabeth M; Pastura, Patricia A et al. (2009) Early growth response-1 suppresses epidermal growth factor receptor-mediated airway hyperresponsiveness and lung remodeling in mice. Am J Respir Cell Mol Biol 41:415-25
Wang, Mei; Bridges, James P; Na, Cheng-Lun et al. (2009) Meckel-Gruber syndrome protein MKS3 is required for endoplasmic reticulum-associated degradation of surfactant protein C. J Biol Chem 284:33377-83
Hardie, William D; Glasser, Stephan W; Hagood, James S (2009) Emerging concepts in the pathogenesis of lung fibrosis. Am J Pathol 175:3-16
Korfhagen, Thomas R; Le Cras, Timothy D; Davidson, Cynthia R et al. (2009) Rapamycin prevents transforming growth factor-alpha-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 41:562-72

Showing the most recent 10 out of 91 publications